Elite in Acne

Dr. Michael H. Gold

Dermatology
Gold Skin Care Center
Gold Skin Care Center PLC
2000 Richard Jones Rd, 
Nashville, TN 
Accepting New Patients
Elite in Acne
Gold Skin Care Center
Gold Skin Care Center PLC
2000 Richard Jones Rd, 
Nashville, TN 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Michael Gold is a Dermatologist in Nashville, Tennessee. Dr. Gold is rated as an Elite provider by MediFind in the treatment of Acne. His top areas of expertise are Acne, Keloids, Athlete's Foot, and Melasma. Dr. Gold is currently accepting new patients.

His clinical research consists of co-authoring 429 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 51 articles and participated in 1 clinical trial in the study of Acne.

Specialties
Dermatology
Licenses
Specialist in TN
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Farm Bureau Health Plans
  • HMO
  • MEDICARE MAPD
  • MEDICARE PDP
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Mutual
  • HMO
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

Gold Skin Care Center PLC
2000 Richard Jones Rd, Nashville, TN 37215
Call: 615-383-2400

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

A Feasibility Study to Evaluate Preliminary Safety and Effectiveness of SMI-01 as a Tissue Filler
A Feasibility Study to Evaluate Preliminary Safety and Effectiveness of SMI-01 as a Tissue Filler
Enrollment Status: Completed
Publish Date: May 31, 2024
Intervention Type: Device
Study Phase: Not Applicable
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intralesional Injection of STP705 in Adult Patients With Cutaneous Squamous Cell Carcinoma in Situ (isSCC)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intralesional Injection of STP705 in Adult Patients With Cutaneous Squamous Cell Carcinoma in Situ (isSCC)
Enrollment Status: Completed
Publish Date: March 18, 2024
Intervention Type: Drug, Other
Study Drug: STP705
Study Phase: Phase 2
A Pivotal USA Randomized, Evaluator-blinded, Active-controlled, Multi-center, Split-face Comparison Study of Emervel® Deep Lidocaine Versus Juvederm® Ultra Plus in the Treatment of Moderate to Severe Facial Wrinkles and Folds
A Pivotal USA Randomized, Evaluator-blinded, Active-controlled, Multi-center, Split-face Comparison Study of Emervel® Deep Lidocaine Versus Juvederm® Ultra Plus in the Treatment of Moderate to Severe Facial Wrinkles and Folds
Enrollment Status: Completed
Publish Date: October 23, 2023
Intervention Type: Device
Study Phase: Not Applicable
A Phase II, Open Label Study of Bermekimab in Patients With Moderate to Severe Hidradenitis Suppurativa
A Phase II, Open Label Study of Bermekimab in Patients With Moderate to Severe Hidradenitis Suppurativa
Enrollment Status: Completed
Publish Date: March 14, 2022
Intervention Type: Drug
Study Phase: Phase 2
A Multi-Phase, Prospective, Multi-Center, Single-Blind, Clinical Study to Evaluate the Safety and Efficacy of Allograft Adipose Matrix (AAM) and Diluted AAM for Pre-Jowl and Malar Augmentation to Correct Age Related Volume Deficit in the Face
A Multi-Phase, Prospective, Multi-Center, Single-Blind, Clinical Study to Evaluate the Safety and Efficacy of Allograft Adipose Matrix (AAM) and Diluted AAM for Pre-Jowl and Malar Augmentation to Correct Age Related Volume Deficit in the Face
Enrollment Status: Completed
Publish Date: May 11, 2021
Intervention Type: Procedure
Study Phase: Not Applicable
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: May 04, 2021
Intervention Type: Drug, Biological
Study Phase: Phase 2
A Phase 3, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of Cortexolone 17α-Propionate (CB-03-01) Cream, 1% Applied Twice Daily for 12 Weeks in Subjects With Facial Acne Vulgaris
A Phase 3, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of Cortexolone 17α-Propionate (CB-03-01) Cream, 1% Applied Twice Daily for 12 Weeks in Subjects With Facial Acne Vulgaris
Enrollment Status: Completed
Publish Date: November 20, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Randomized, Double-Blind, Active- and Vehicle-Controlled Study to Compare the Efficacy and Safety of Products S2G6T-1, S2G6T-2, S2G6T-3 and S2G6T-4 in Patients With Symptomatic Inflammatory Interdigital Tinea Pedis
A Randomized, Double-Blind, Active- and Vehicle-Controlled Study to Compare the Efficacy and Safety of Products S2G6T-1, S2G6T-2, S2G6T-3 and S2G6T-4 in Patients With Symptomatic Inflammatory Interdigital Tinea Pedis
Enrollment Status: Terminated
Publish Date: November 18, 2020
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter, Double-Blind, Randomized, Split-Face Study to Evaluate the Safety and Efficacy of Revanesse® Ultra + (With Lidocaine) Versus Revanesse® Ultra for the Correction of Nasolabial Folds (NLF)
A Multicenter, Double-Blind, Randomized, Split-Face Study to Evaluate the Safety and Efficacy of Revanesse® Ultra + (With Lidocaine) Versus Revanesse® Ultra for the Correction of Nasolabial Folds (NLF)
Enrollment Status: Completed
Publish Date: April 11, 2019
Intervention Type: Device
Study Phase: Not Applicable
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of LIPO-202 (Salmeterol Xinafoate for Injection) for the Reduction of Submental Subcutaneous Fat
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of LIPO-202 (Salmeterol Xinafoate for Injection) for the Reduction of Submental Subcutaneous Fat
Enrollment Status: Completed
Publish Date: October 20, 2017
Intervention Type: Drug
Study Phase: Phase 2
View 9 Less Clinical Trials

429 Total Publications

GLP-1 Receptor Agonists in Hidradenitis Suppurativa: A Novel Therapeutic Approach for Hidradenitis Suppurativa and Its Comorbidities.
GLP-1 Receptor Agonists in Hidradenitis Suppurativa: A Novel Therapeutic Approach for Hidradenitis Suppurativa and Its Comorbidities.
Journal: Journal of drugs in dermatology : JDD
Published: December 02, 2025
View All 429 Publications
Similar Doctors
Advanced in Acne
Dr. John M. Hardin
Dermatology
Advanced in Acne
Dr. John M. Hardin
Dermatology

Heritage Medical Associates PC

2325 Crestmoor Rd, Suite 104, 
Nashville, TN 
 (0.6 miles away)
629-255-2202
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

John Hardin is a Dermatologist in Nashville, Tennessee. Dr. Hardin is rated as an Advanced provider by MediFind in the treatment of Acne. His top areas of expertise are Hypomelanosis of Ito, PARC Syndrome, Acne, and Melanoma. Dr. Hardin is currently accepting new patients.

Advanced in Acne
Dr. Heidi K. Rinderer
Dermatology
Advanced in Acne
Dr. Heidi K. Rinderer
Dermatology

Heritage Medical Associates PC

222 22nd Ave N, 
Nashville, TN 
 (3.3 miles away)
629-255-3486
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Heidi Rinderer is a Dermatologist in Nashville, Tennessee. Dr. Rinderer is rated as a Distinguished provider by MediFind in the treatment of Acne. Her top areas of expertise are Impetigo, Multiple Familial Trichoepithelioma, Trichoepithelioma, and Actinic Keratosis. Dr. Rinderer is currently accepting new patients.

Advanced in Acne
Dr. Leslie J. Caudill
Dermatology
Advanced in Acne
Dr. Leslie J. Caudill
Dermatology

Heritage Medical Associates PC

222 22nd Ave N, 
Nashville, TN 
 (3.3 miles away)
629-255-3486
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Leslie Caudill is a Dermatologist in Nashville, Tennessee. Dr. Caudill is rated as a Distinguished provider by MediFind in the treatment of Acne. Her top areas of expertise are Trichoepithelioma, Multiple Familial Trichoepithelioma, Syringoma, and Sebaceous Adenoma. Dr. Caudill is currently accepting new patients.

VIEW MORE ACNE DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Gold's expertise for a condition
ConditionClose
  • Elite
  • Acne
    Dr. Gold is
    Elite
    . Learn about Acne.
    See more Acne experts
  • Keloids
    Dr. Gold is
    Elite
    . Learn about Keloids.
    See more Keloids experts
  • Distinguished
  • Athlete's Foot
    Dr. Gold is
    Distinguished
    . Learn about Athlete's Foot.
    See more Athlete's Foot experts
  • Autosomal Recessive Hypotrichosis
    Dr. Gold is
    Distinguished
    . Learn about Autosomal Recessive Hypotrichosis.
    See more Autosomal Recessive Hypotrichosis experts
  • Comedones
    Dr. Gold is
    Distinguished
    . Learn about Comedones.
    See more Comedones experts
  • GAPO Syndrome
    Dr. Gold is
    Distinguished
    . Learn about GAPO Syndrome.
    See more GAPO Syndrome experts
  • Jock Itch
    Dr. Gold is
    Distinguished
    . Learn about Jock Itch.
    See more Jock Itch experts
  • Melasma
    Dr. Gold is
    Distinguished
    . Learn about Melasma.
    See more Melasma experts
  • Advanced
  • Actinic Keratosis
    Dr. Gold is
    Advanced
    . Learn about Actinic Keratosis.
    See more Actinic Keratosis experts
  • Alopecia Areata
    Dr. Gold is
    Advanced
    . Learn about Alopecia Areata.
    See more Alopecia Areata experts
  • Familial Multiple Nevi Flammei
    Dr. Gold is
    Advanced
    . Learn about Familial Multiple Nevi Flammei.
    See more Familial Multiple Nevi Flammei experts
  • Hidradenitis Suppurativa
    Dr. Gold is
    Advanced
    . Learn about Hidradenitis Suppurativa.
    See more Hidradenitis Suppurativa experts
  • Membranous Nephropathy
    Dr. Gold is
    Advanced
    . Learn about Membranous Nephropathy.
    See more Membranous Nephropathy experts
  • Papular Urticaria
    Dr. Gold is
    Advanced
    . Learn about Papular Urticaria.
    See more Papular Urticaria experts
View All 17 Advanced Conditions
  • Experienced
  • Atopic Dermatitis
    Dr. Gold is
    Experienced
    . Learn about Atopic Dermatitis.
    See more Atopic Dermatitis experts
  • Basal Cell Skin Cancer
    Dr. Gold is
    Experienced
    . Learn about Basal Cell Skin Cancer.
    See more Basal Cell Skin Cancer experts
  • Bowen's Disease
    Dr. Gold is
    Experienced
    . Learn about Bowen's Disease.
    See more Bowen's Disease experts
  • Cerebral Cavernous Malformation
    Dr. Gold is
    Experienced
    . Learn about Cerebral Cavernous Malformation.
    See more Cerebral Cavernous Malformation experts
  • Cherry Angioma
    Dr. Gold is
    Experienced
    . Learn about Cherry Angioma.
    See more Cherry Angioma experts
  • Chronic Spontaneous Urticaria (CSU)
    Dr. Gold is
    Experienced
    . Learn about Chronic Spontaneous Urticaria (CSU).
    See more Chronic Spontaneous Urticaria (CSU) experts
View All 50 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request a Doctor Appointment

    Please fill out the details in the form below to allow MediFind to submit an appointment request to Dr. Michael H. Gold's office on your behalf. Your provider may contact you directly to complete scheduling. If you are experiencing a medical emergency, please call 9-1-1. This form is for appointment requests only. Currently, we are not accepting appointments from users outside of the US.

        Close
        0 / 1000

        Please provide us with the below insurance information:

        By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.